LA JOLLA, California, June 2 -- The University of California San Diego campus posted the following news:

* * *

Study: Popular GLP-1 Drug May Slow Down Biological Aging

*

Key Takeaways

* Semaglutide slowed biological aging across multiple epigenetic clocks in a randomized, double-blind, placebo-controlled clinical trial.

* The strongest signals were seen in epigenetic measures linked to inflammation, brain, heart, . . .

Click here for more information about our products